SCHEMBL24316216

SCHEMBL24316216

CC(C)NC1CCCCC1NC1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
HSD17B10 Q99714 1/20 0.48
KDM4E B2RXH2 2/20 0.35
ATM Q13315 2/20 0.35
PIM1 P11309 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
GAA P10253 1/20 0.34
EPHX1 P07099 3/20 0.33
THRB P10828 1/20 0.33
MGAM O43451 1/20 0.33
SI P14410 1/20 0.33
SIGMAR1 Q99720 2/20 0.31
BCHE P06276 1/20 0.31
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22647693 0.85 PIM1 (0.41) ALDH1A1HSD17B10KDM4EATMPIM1
SCHEMBL20061131 0.83 ALDH1A1 (0.69) ALDH1A1HSD17B10KDM4EEPHX1MGAM
SCHEMBL4739291 0.83 ALDH1A1 (0.69) ALDH1A1HSD17B10KDM4EEPHX1MGAM
SCHEMBL4417021 0.83 PIM1 (0.42) KDM4EATMPIM1L3MBTL1GAA
SCHEMBL13303583 0.83 PIM1 (0.42) KDM4EATMPIM1L3MBTL1GAA
SCHEMBL20061124 0.83 PIM1 (0.42) KDM4EATMPIM1L3MBTL1GAA
SCHEMBL20061142 0.83 ALDH1A1 (0.69) ALDH1A1HSD17B10KDM4EEPHX1MGAM
SCHEMBL20061122 0.80 ALDH1A1 (0.62) ALDH1A1HSD17B10KDM4EEPHX1MGAM
SCHEMBL20061125 0.80 ALDH1A1 (0.62) ALDH1A1HSD17B10KDM4EEPHX1MGAM
Hydrochloric Acid SCHEMBL6656735 0.78 PIM1 (0.40) KDM4EPIM1L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed
US-9585884-B2 Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 AUSPEX PHARMACEUTICALS, INC. (US) 2017-03-07 US disclosed